ELAVL1 and lung carcinoma: Another study evaluated the efficacy of folate receptor-α (FRA)-targeted DOTAP:cholesterol lipid nanoparticles (HuR-FNP) carrying HuR siRNA in suppressing lung cancer cell proliferation and migration.